Frequently Asked Questions
The market is segmented based on , By Capacity (1-10L, 10-50L, 50-100L, and 100-500L), Material (Glass, Stainless Steel and Single-Use), Control Type (Automated and Manual), Suppliers (Original Equipment Manufacturers, System Integrators and Engineering Procurement and Construction), End User (Biopharmaceuticals Industry, Academic Institute, and Research Laboratories), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
.
The Global Portable Bioprocessing Bioreactors Market size was valued at USD 2014.03 USD Million in 2020.
The Global Portable Bioprocessing Bioreactors Market is projected to grow at a CAGR of 9.33% during the forecast period of 2021 to 2028.
The major players operating in the market include Thermo Fisher Scientific Inc., Merck Sharp & Dohme Corp., Sartorius AG, GENERAL ELECTRIC COMPANY, Avantor Fluid Handling LLC, CESCO BIOENGINEERING CO.Ltd., Takeda Pharmaceutical Company Limited., FermEx, Uma Pharmatech Machinery., Danaher., Eppendorf AG, Bio-Rad LaboratoriesInc., PerkinElmer Inc., Fluor Corporation., 3M, Applikon Biotechnology, Cellexus, PARKER HANNIFIN CORP, Broadley-James and Solvay .
